Skip to content
Research Article Open access CC BY 4.0

Exploring the Potential Relationship between Malaria Immunity and COVID-19 Protection

Tareef Fadhil Raham, Hamid Shehab Hamid, Zaher Fadhil Raham

Asian Journal of Research in Infectious Diseases · pp. 42–50 · Published 14 May 2024

10.9734/ajrid/2024/v15i5349

Abstract

Although coronavirus disease 2019 (COVID-19) has led to significant morbidity and mortality worldwide, countries in the equatorial and tropical zones seem to have the lowest figures in terms of incidence and mortality. Throughout the pandemic, Africa has remained as lowest continent of accumulative cases and deaths. Since the African region is characterized by a high prevalence of malaria, the lowest number of cases of confirmed COVID-19 attracts scientists to look for possible links between the two diseases. Through this article, we reviewed existing literature concerning a possible explanation between low incidence and less severe COVID-19 in malaria-endemic areas. Different explanations were reviewed including malaria-COVID-19 cross-immunity, population structure, specific receptor’s role, and Vitamin D. The most important factor investigated was malaria immunity through previous exposure (s) which possibly explains these associations.

Malaria COVID-19 Plasmodium spp. SARS-CoV-2 cross-immunity malaria endemic countries

References (56)

  1. 1 Global tuberculosis report (2014)
  2. 2 COVID-19: consider cytokine storm syndromes and immunosuppression [DOI]
  3. 3 Defining trained immunity and its role in health and disease [DOI]
  4. 4 Trained Immunity: A Memory for Innate Host Defense [DOI]
  5. 5 Co-infections in people with COVID-19: a systematic review and meta-analysis [DOI]
  6. 6 Virology, Epidemiology, Pathogenesis, and Control of COVID-19 [DOI]
  7. 7 Acquired Immunity to Malaria [DOI]
  8. 8 Current vitamin D status in European and Middle East countries and strategies to prevent vitamin D deficiency: a position statement of the European Calcified Tissue Society [DOI]
  9. 9 Vitamin D status in the United States, 2011–2014 [DOI]
  10. 10 Associations between blood type and COVID-19 infection, intubation, and death [DOI]
  11. 11 Vitamin D and African Americans [DOI]
  12. 12 SARS-CoV-2 seroprevalence worldwide: a systematic review and meta-analysis [DOI]
  13. 13 ABO Blood Group and Susceptibility to Severe Acute Respiratory Syndrome [DOI]
  14. 14 Prevalence of vitamin D deficiency in Africa: a systematic review and meta-analysis [DOI]
  15. 15 Circulating ACE2 activity is increased in patients with type 1 diabetes and vascular complications [DOI]
  16. 16 The vitamin D status of the US population from 1988 to 2010 using standardized serum concentrations of 25-hydroxyvitamin D shows recent modest increases [DOI]
  17. 17 Africa’s low COVID-19 mortality rate: A paradox? [DOI]
  18. 18 Antimalarial drugs inhibit the replication of SARS-CoV-2: An in vitro evaluation [DOI]
  19. 19 Global Spread of Coronavirus Disease 2019 and Malaria: An Epidemiological Paradox in the Early Stage of A Pandemic [DOI]
  20. 20 The role of vitamin D deficiency on COVID-19: a systematic review and meta-analysis of observational studies [DOI]
  21. 21 Malaria and COVID-19: Common and Different Findings [DOI]
  22. 22 Low incidence of COVID-19 case severity and mortality in Africa; Could malaria co-infection provide the missing link? [DOI]
  23. 23 Prevalence and predictors of vitamin D deficiency in a nationally representative sample of adults participating in the 2011–2013 Australian Health Survey [DOI]
  24. 24 SARS-CoV-2 and Plasmodium falciparum common immunodominant regions may explain low COVID-19 incidence in the malaria-endemic belt [DOI]
  25. 25 Prevalence and characteristics of malaria among COVID-19 individuals: A systematic review, meta-analysis, and analysis of case reports [DOI]
  26. 26 Current malaria infection, previous malaria exposure, and clinical profiles and outcomes of COVID-19 in a setting of high malaria transmission: an exploratory cohort study in Uganda [DOI]
  27. 27 Screening Malaria-box compounds to identify potential inhibitors against SARS-CoV-2 Mpro, using molecular docking and dynamics simulation studies [DOI]
  28. 28 Impact of COVID-19 and malaria coinfection on clinical outcomes: a retrospective cohort study [DOI]
  29. 29 Co‐infection of malaria and early clearance of SARS‐CoV‐2 in healthcare workers [DOI]
  30. 30 Hydroxychloroquine is effective, and consistently so when provided early, for COVID-19: a systematic review [DOI]
  31. 31 Sars-CoV-2 and black population: ACE2 as shield or blade? [DOI]
  32. 32 Unraveling the Epidemiology, Geographical Distribution, and Genomic Evolution of Potentially Lethal Coronaviruses (SARS, MERS, and SARS CoV-2) [DOI]
  33. 33 How Genetics Might Explain the Unusual Link Between Malaria and COVID-19 [DOI]
  34. 34 Is hypertension in African-descent populations contributed to by an imbalance in the activities of the ACE2/Ang-(1-7)/Mas and the ACE/Ang II/AT 1 axes? [DOI]
  35. 35 Influence of malaria endemicity and tuberculosis prevalence on COVID-19 mortality [DOI]
  36. 36 Incidence of coronavirus disease (COVID-19) and countries affected by malarial infections [DOI]
  37. 37 An elevated 8-isoprostaglandin F2 alpha (8-iso-PGF2α) in COVID-19 subjects co-infected with malaria [DOI]
  38. 38 ACE2 mutation might explain lower COVID-19 burden in malaria endemic areas [DOI]
  39. 39 25‐hydroxyvitamin D levels in African American and Nigerian women [DOI]
  40. 40 The association between malaria prevalence and COVID-19 mortality [DOI]
  41. 41 The role of leukocytes bearing Natural Killer Complex receptors and Killer Immunoglobulin-like Receptors in the immunology of malaria [DOI]
  42. 42 Is COVID-19 Fatality Rate Associated with Malaria Endemicity? [DOI]
  43. 43 Is the New Coronavirus Disease (COVID-19) Pandemic Halted by Malaria Epidemics? [DOI]
  44. 44 H1N1 and COVID-19: surprising mortality pattern correlation [DOI]
  45. 45 BCG Correlation with Latent Tuberculosis Can Lead to Spurious Correlation with Reduced COVID-19 Mortality [DOI]
  46. 46 Does vitamin D status impact mortality from SARS-CoV-2 infection? [DOI]
  47. 47 ACE-1 I/D Polymorphism Associated with COVID-19 Incidence and Mortality: An Ecological Study [DOI]
  48. 48 Comparative analyses revealed reduced spread of COVID-19 in malaria endemic countries [DOI]
  49. 49 Finding Tentative Causes for the reduced impact of Covid-19 on the Health Systems of poorer and developing nations: An ecological study of the effect of demographic, climatological and health-related factors on the global spread of Covid-19 [DOI]
  50. 50 Impact of Duration of Cessation of Mass BCG Vaccination Programs on COVID-19 Mortality [DOI]
  51. 51 SARS-CoV-2 infection in Africa: a systematic review and meta-analysis of standardised seroprevalence studies, from January 2020 to December 2021 [DOI]
  52. 52 The COVID-19 pandemic in the African continent [DOI]
  53. 53 The striking mimics between COVID-19 and malaria: A review [DOI]
  54. 54 Exploring SARS-CoV-2 and Plasmodium falciparum coinfection in human erythrocytes [DOI]
  55. 55 Population Growth Rates and Pattern of COVID-19 Deaths Per Million [DOI]
  56. 56 10.48112/bcs.v1i2 [DOI]

Cited by 0

No indexed citations yet.

Article metrics

Real usage data collected on this platform.

60

Page views

0

PDF downloads

15

Outbound clicks

0

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.